"Arthritis, Psoriatic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A type of inflammatory arthritis associated with PSORIASIS, often involving the axial joints and the peripheral terminal interphalangeal joints. It is characterized by the presence of HLA-B27-associated SPONDYLARTHROPATHY, and the absence of rheumatoid factor.
| Descriptor ID |
D015535
|
| MeSH Number(s) |
C05.116.900.853.625.800.424 C05.550.114.145 C05.550.114.865.800.424 C17.800.859.675.175
|
| Concept/Terms |
Arthritis, Psoriatic- Arthritis, Psoriatic
- Psoriasis, Arthritic
- Arthritic Psoriasis
- Psoriatic Arthritis
- Psoriasis Arthropathica
- Psoriatic Arthropathy
- Arthropathies, Psoriatic
- Arthropathy, Psoriatic
- Psoriatic Arthropathies
|
Below are MeSH descriptors whose meaning is more general than "Arthritis, Psoriatic".
Below are MeSH descriptors whose meaning is more specific than "Arthritis, Psoriatic".
This graph shows the total number of publications written about "Arthritis, Psoriatic" by people in this website by year, and whether "Arthritis, Psoriatic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 1 | 2 |
| 2015 | 2 | 0 | 2 |
| 2016 | 4 | 0 | 4 |
| 2017 | 52 | 3 | 55 |
| 2018 | 57 | 11 | 68 |
| 2019 | 38 | 4 | 42 |
| 2020 | 11 | 10 | 21 |
| 2021 | 7 | 0 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Arthritis, Psoriatic" by people in Profiles.
-
SARS-CoV-2 IgM False-Positivity in a Psoriatic Arthritis Patient Seropositive for Rheumatoid Factor and ACPA: An Interference of Immune Response? J Clin Rheumatol. 2021 Dec 01; 27(8S):S868.
-
Impact of the COVID-19 pandemic on treat-to-target strategies and physical consultations in >7000 patients with inflammatory arthritis. Rheumatology (Oxford). 2021 10 09; 60(SI):SI3-SI12.
-
Assessing the Risk and Outcome of COVID-19 in Patients with Psoriasis or Psoriatic Arthritis on Biologic Treatment: A Critical Appraisal of the Quality of the Published Evidence. J Invest Dermatol. 2022 02; 142(2):355-363.e7.
-
Patient educational needs and challenges in psoriatic arthritis. Curr Opin Rheumatol. 2021 07 01; 33(4):356-362.
-
Prologue: 2020 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). J Rheumatol Suppl. 2021 Jun; 97:1-3.
-
Psoriasis and Psoriatic Arthritis in the Context of the COVID-19 Pandemic: A Plenary Session From the GRAPPA 2020 Annual Meeting. J Rheumatol Suppl. 2021 Jun; 97:24-29.
-
GRAPPA 2020 Update From the Education Committee. J Rheumatol Suppl. 2021 Jun; 97:58-59.
-
GRAPPA Patient Research Partner Network: Update to the GRAPPA 2020 Annual Meeting. J Rheumatol Suppl. 2021 Jun; 97:64.
-
Use of telemedicine during the COVID-19 pandemic in patients with inflammatory arthritis: a retrospective study on feasibility and impact on patient-reported outcomes in a real-life setting. Rheumatol Int. 2021 07; 41(7):1253-1261.
-
Development of an Instrument for Patient Self-assessment in Psoriatic Arthritis. J Rheumatol. 2021 Nov; 48(11):1680-1685.